marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Axsome Therapeutics Income Statement 2011-2024 | AXSM
Annual Income Statement Axsome Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.59 B | 3.21 B | 1.03 B | 2.54 B | 3.01 B | 224 M | 63.7 M | 90 M | 93.5 M | - | - | - | - |
Shares |
45.4 M | 40.7 M | 37.6 M | 37.4 M | 34 M | 26.9 M | 22.8 M | 19.2 M | 11.9 M | - | - | - | - |
Historical Prices |
79 | 79 | 27.4 | 68.1 | 86.8 | 8.39 | 2.8 | 4.9 | 7.83 | - | - | - | - |
Net Income |
-239 M | -187 M | -130 M | -103 M | -68.3 M | -31 M | -28.9 M | -27.2 M | -10.6 M | -6 M | -2.17 M | - | - |
Revenue |
271 M | 50 M | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
26.1 M | 5.2 M | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-232 M | -180 M | -125 M | -99.1 M | -67.2 M | -32.8 M | -27.2 M | -27.5 M | -9.2 M | -5.67 M | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-231 M | -180 M | -125 M | -99 M | -67.1 M | -32.6 M | -26.9 M | -27 M | -6.91 M | -2.74 M | -1.84 M | - | - |
Operating Expenses |
- | - | - | 99.1 M | 67.1 M | 32.6 M | 27 M | 27.1 M | - | - | - | - | - |
General and Administrative Expenses |
323 M | 159 M | 66.6 M | 28.9 M | 13.6 M | 9.35 M | 7.21 M | 6.34 M | 2.42 M | 1.39 M | 304 K | - | - |
All numbers in USD currency
Quarterly Income Statement Axsome Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
48.1 M | 47.6 M | 47.4 M | 47.4 M | 47.1 M | 43.7 M | 43.5 M | 43.5 M | 41.7 M | 39.1 M | 38.3 M | 37.8 M | 37.7 M | 37.6 M | 37.4 M | 37.4 M | 37.3 M | 37.1 M | 37.1 M | 36.9 M | 34.4 M | 33.8 M | 33.1 M | 30.1 M | 26.3 M | 25.8 M | 25.5 M | 25.5 M | 23.6 M | 23.6 M | 19.5 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 11.1 M | 11.1 M | 11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-64.6 M | -79.3 M | -68.4 M | - | -62.2 M | -67.2 M | -11.2 M | - | -44.8 M | -41.4 M | -39.6 M | - | -34.9 M | -32.3 M | -29.3 M | -29.2 M | -22.9 M | -18.3 M | -32.5 M | -24.8 M | -19.1 M | -13.8 M | -10.6 M | -9.6 M | -8.28 M | -8.28 M | -4.81 M | -7.43 M | -6.43 M | -7.08 M | -8 M | -7.33 M | -7.19 M | -6.81 M | -5.87 M | -3.36 M | -4.58 M | -2.13 M | -2.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
105 M | 87.2 M | 75 M | - | 57.8 M | 46.7 M | 94.6 M | - | 16.8 M | 8.82 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
8.44 M | 8.06 M | 6.3 M | - | 6.53 M | 4.6 M | 7.56 M | - | 1.92 M | 983 K | - | - | - | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-62.6 M | -78 M | -67.3 M | - | -62.1 M | -65.1 M | -6.37 M | - | -42.4 M | -39.2 M | -38.3 M | - | -33.4 M | -30.8 M | -27.8 M | - | -21.1 M | -17.8 M | -32.5 M | - | -18.9 M | -13.4 M | -10.4 M | 9.45 M | -8.24 M | -7.99 M | -7.16 M | 6.44 M | 6.3 M | 6.75 M | 7.67 M | 7.63 M | 7.21 M | 6.83 M | 5.88 M | 3.15 M | 2.02 M | 2.08 M | 1.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-61 M | -76.5 M | -67.1 M | - | -60.5 M | -63.5 M | -6.28 M | - | -40.8 M | -38.3 M | -38.3 M | - | -33.4 M | -30.8 M | -27.8 M | - | -21.1 M | -17.8 M | -32.5 M | - | -18.9 M | -13.4 M | -10.4 M | 9.45 M | -8.21 M | -7.97 M | -7.15 M | 6.44 M | 6.33 M | 6.77 M | 7.68 M | 7.63 M | 7.22 M | 6.83 M | 5.88 M | 3.15 M | 2.03 M | 2.09 M | 1.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | 38.3 M | - | 33.4 M | 30.8 M | 27.8 M | 27.7 M | 21.1 M | 17.8 M | 32.5 M | 24.4 M | 18.9 M | 13.4 M | 10.4 M | 9.45 M | 8.24 M | 7.99 M | 7.16 M | - | 6.3 M | 6.75 M | 7.67 M | - | 7.21 M | 6.83 M | 5.88 M | - | 2.02 M | 2.08 M | 1.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
95.6 M | 104 M | 99 M | - | 83.2 M | 78.9 M | 74.2 M | - | 40.9 M | 31.2 M | 25.7 M | - | 20.2 M | 16.3 M | 11.2 M | - | 6.33 M | 7.24 M | 4.97 M | - | 3.11 M | 2.45 M | 2.82 M | - | 2.2 M | 2.44 M | 2.41 M | - | 1.83 M | 1.74 M | 1.69 M | - | 1.64 M | 1.53 M | 1.36 M | - | 499 K | 456 K | 517 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency